Stock NAMS NEWAMSTERDAM PHARMA COMPANY N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart NewAmsterdam Pharma Company N.V. Nasdaq

Equities

NAMS

NL00150012L7

Real-time Estimate Cboe BZX
Other stock markets
 10:57:36 2024-07-12 am EDT 		5-day change 1st Jan Change
19.96 USD -4.91% Intraday chart for NewAmsterdam Pharma Company N.V. +4.95% +87.91%
Jul. 08 NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment MT
Jul. 08 NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEWAMSTERDAM PHARMA COMPANY N.V.
Bio Therapeutic Drugs
-3.53%+4.95% - - - 1.89B - - -
  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. NAMS Stock
  5. Charts NewAmsterdam Pharma Company N.V.
  6. Relative Strength Chart